世界のTCR-T療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global TCR-T Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5565
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、TCR-T療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自家、同種異系）、用途別市場規模（難治性再発黒色腫、滑膜肉腫、多発性骨髄腫、肺がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・TCR-T療法の市場動向
・企業の競争状況、市場シェア
・TCR-T療法の種類別市場規模（自家、同種異系）
・TCR-T療法の用途別市場規模（難治性再発黒色腫、滑膜肉腫、多発性骨髄腫、肺がん、その他）
・TCR-T療法の北米市場規模2016-2027（アメリカ、カナダ）
・TCR-T療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・TCR-T療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・TCR-T療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・TCR-T療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Athenex、Xiangxue Pharmaceutical (Xiangxue Precision)、Hengrui Yuanzheng、Eureka Therapeutics、WuXi Juno、Shenzhen Inno Immunity、Shenzhen Binde Bio、Kerui Bio）
・結論

Market Analysis and Insights: Global TCR-T Therapy Market
The global TCR-T Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global TCR-T Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global TCR-T Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global TCR-T Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global TCR-T Therapy market.

Global TCR-T Therapy Scope and Market Size
TCR-T Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global TCR-T Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Source of T-cells and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Source of T-cells
Autologous
Allogeneic

Segment by Application
Refractory Relapsed Melanoma
Synovial Sarcoma
Multiple Myeloma
Lung Cancer
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Athenex
Xiangxue Pharmaceutical (Xiangxue Precision)
Hengrui Yuanzheng
Eureka Therapeutics
WuXi Juno
Shenzhen Inno Immunity

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TCR-T Therapy Market Size Growth Rate by Source of T-cells: 2016 VS 2021 VS 2027
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global TCR-T Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Refractory Relapsed Melanoma
1.3.3 Synovial Sarcoma
1.3.4 Multiple Myeloma
1.3.5 Lung Cancer
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global TCR-T Therapy Market Perspective (2016-2027)
2.2 TCR-T Therapy Growth Trends by Regions
2.2.1 TCR-T Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 TCR-T Therapy Historic Market Share by Regions (2016-2021)
2.2.3 TCR-T Therapy Forecasted Market Size by Regions (2022-2027)
2.3 TCR-T Therapy Industry Dynamic
2.3.1 TCR-T Therapy Market Trends
2.3.2 TCR-T Therapy Market Drivers
2.3.3 TCR-T Therapy Market Challenges
2.3.4 TCR-T Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top TCR-T Therapy Players by Revenue
3.1.1 Global Top TCR-T Therapy Players by Revenue (2016-2021)
3.1.2 Global TCR-T Therapy Revenue Market Share by Players (2016-2021)
3.2 Global TCR-T Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by TCR-T Therapy Revenue
3.4 Global TCR-T Therapy Market Concentration Ratio
3.4.1 Global TCR-T Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TCR-T Therapy Revenue in 2020
3.5 TCR-T Therapy Key Players Head office and Area Served
3.6 Key Players TCR-T Therapy Product Solution and Service
3.7 Date of Enter into TCR-T Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 TCR-T Therapy Breakdown Data by Source of T-cells
4.1 Global TCR-T Therapy Historic Market Size by Source of T-cells (2016-2021)
4.2 Global TCR-T Therapy Forecasted Market Size by Source of T-cells (2022-2027)

5 TCR-T Therapy Breakdown Data by Application
5.1 Global TCR-T Therapy Historic Market Size by Application (2016-2021)
5.2 Global TCR-T Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America TCR-T Therapy Market Size (2016-2027)
6.2 North America TCR-T Therapy Market Size by Source of T-cells
6.2.1 North America TCR-T Therapy Market Size by Source of T-cells (2016-2021)
6.2.2 North America TCR-T Therapy Market Size by Source of T-cells (2022-2027)
6.2.3 North America TCR-T Therapy Market Size by Source of T-cells (2016-2027)
6.3 North America TCR-T Therapy Market Size by Application
6.3.1 North America TCR-T Therapy Market Size by Application (2016-2021)
6.3.2 North America TCR-T Therapy Market Size by Application (2022-2027)
6.3.3 North America TCR-T Therapy Market Size by Application (2016-2027)
6.4 North America TCR-T Therapy Market Size by Country
6.4.1 North America TCR-T Therapy Market Size by Country (2016-2021)
6.4.2 North America TCR-T Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe TCR-T Therapy Market Size (2016-2027)
7.2 Europe TCR-T Therapy Market Size by Source of T-cells
7.2.1 Europe TCR-T Therapy Market Size by Source of T-cells (2016-2021)
7.2.2 Europe TCR-T Therapy Market Size by Source of T-cells (2022-2027)
7.2.3 Europe TCR-T Therapy Market Size by Source of T-cells (2016-2027)
7.3 Europe TCR-T Therapy Market Size by Application
7.3.1 Europe TCR-T Therapy Market Size by Application (2016-2021)
7.3.2 Europe TCR-T Therapy Market Size by Application (2022-2027)
7.3.3 Europe TCR-T Therapy Market Size by Application (2016-2027)
7.4 Europe TCR-T Therapy Market Size by Country
7.4.1 Europe TCR-T Therapy Market Size by Country (2016-2021)
7.4.2 Europe TCR-T Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific TCR-T Therapy Market Size (2016-2027)
8.2 Asia-Pacific TCR-T Therapy Market Size by Source of T-cells
8.2.1 Asia-Pacific TCR-T Therapy Market Size by Source of T-cells (2016-2021)
8.2.2 Asia-Pacific TCR-T Therapy Market Size by Source of T-cells (2022-2027)
8.2.3 Asia-Pacific TCR-T Therapy Market Size by Source of T-cells (2016-2027)
8.3 Asia-Pacific TCR-T Therapy Market Size by Application
8.3.1 Asia-Pacific TCR-T Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific TCR-T Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific TCR-T Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific TCR-T Therapy Market Size by Region
8.4.1 Asia-Pacific TCR-T Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific TCR-T Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America TCR-T Therapy Market Size (2016-2027)
9.2 Latin America TCR-T Therapy Market Size by Source of T-cells
9.2.1 Latin America TCR-T Therapy Market Size by Source of T-cells (2016-2021)
9.2.2 Latin America TCR-T Therapy Market Size by Source of T-cells (2022-2027)
9.2.3 Latin America TCR-T Therapy Market Size by Source of T-cells (2016-2027)
9.3 Latin America TCR-T Therapy Market Size by Application
9.3.1 Latin America TCR-T Therapy Market Size by Application (2016-2021)
9.3.2 Latin America TCR-T Therapy Market Size by Application (2022-2027)
9.3.3 Latin America TCR-T Therapy Market Size by Application (2016-2027)
9.4 Latin America TCR-T Therapy Market Size by Country
9.4.1 Latin America TCR-T Therapy Market Size by Country (2016-2021)
9.4.2 Latin America TCR-T Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa TCR-T Therapy Market Size (2016-2027)
10.2 Middle East & Africa TCR-T Therapy Market Size by Source of T-cells
10.2.1 Middle East & Africa TCR-T Therapy Market Size by Source of T-cells (2016-2021)
10.2.2 Middle East & Africa TCR-T Therapy Market Size by Source of T-cells (2022-2027)
10.2.3 Middle East & Africa TCR-T Therapy Market Size by Source of T-cells (2016-2027)
10.3 Middle East & Africa TCR-T Therapy Market Size by Application
10.3.1 Middle East & Africa TCR-T Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa TCR-T Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa TCR-T Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa TCR-T Therapy Market Size by Country
10.4.1 Middle East & Africa TCR-T Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa TCR-T Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Athenex
11.1.1 Athenex Company Details
11.1.2 Athenex Business Overview
11.1.3 Athenex TCR-T Therapy Introduction
11.1.4 Athenex Revenue in TCR-T Therapy Business (2016-2021)
11.1.5 Athenex Recent Development
11.2 Xiangxue Pharmaceutical (Xiangxue Precision)
11.2.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Details
11.2.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
11.2.3 Xiangxue Pharmaceutical (Xiangxue Precision) TCR-T Therapy Introduction
11.2.4 Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in TCR-T Therapy Business (2016-2021)
11.2.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development
11.3 Hengrui Yuanzheng
11.3.1 Hengrui Yuanzheng Company Details
11.3.2 Hengrui Yuanzheng Business Overview
11.3.3 Hengrui Yuanzheng TCR-T Therapy Introduction
11.3.4 Hengrui Yuanzheng Revenue in TCR-T Therapy Business (2016-2021)
11.3.5 Hengrui Yuanzheng Recent Development
11.4 Eureka Therapeutics
11.4.1 Eureka Therapeutics Company Details
11.4.2 Eureka Therapeutics Business Overview
11.4.3 Eureka Therapeutics TCR-T Therapy Introduction
11.4.4 Eureka Therapeutics Revenue in TCR-T Therapy Business (2016-2021)
11.4.5 Eureka Therapeutics Recent Development
11.5 WuXi Juno
11.5.1 WuXi Juno Company Details
11.5.2 WuXi Juno Business Overview
11.5.3 WuXi Juno TCR-T Therapy Introduction
11.5.4 WuXi Juno Revenue in TCR-T Therapy Business (2016-2021)
11.5.5 WuXi Juno Recent Development
11.6 Shenzhen Inno Immunity
11.6.1 Shenzhen Inno Immunity Company Details
11.6.2 Shenzhen Inno Immunity Business Overview
11.6.3 Shenzhen Inno Immunity TCR-T Therapy Introduction
11.6.4 Shenzhen Inno Immunity Revenue in TCR-T Therapy Business (2016-2021)
11.6.5 Shenzhen Inno Immunity Recent Development
11.7 Shenzhen Binde Bio
11.7.1 Shenzhen Binde Bio Company Details
11.7.2 Shenzhen Binde Bio Business Overview
11.7.3 Shenzhen Binde Bio TCR-T Therapy Introduction
11.7.4 Shenzhen Binde Bio Revenue in TCR-T Therapy Business (2016-2021)
11.7.5 Shenzhen Binde Bio Recent Development
11.8 Kerui Bio
11.8.1 Kerui Bio Company Details
11.8.2 Kerui Bio Business Overview
11.8.3 Kerui Bio TCR-T Therapy Introduction
11.8.4 Kerui Bio Revenue in TCR-T Therapy Business (2016-2021)
11.8.5 Kerui Bio Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global TCR-T Therapy Market Size Growth Rate by Source of T-cells (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Autologous
Table 3. Key Players of Allogeneic
Table 4. Global TCR-T Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global TCR-T Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global TCR-T Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global TCR-T Therapy Market Share by Regions (2016-2021)
Table 8. Global TCR-T Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global TCR-T Therapy Market Share by Regions (2022-2027)
Table 10. TCR-T Therapy Market Trends
Table 11. TCR-T Therapy Market Drivers
Table 12. TCR-T Therapy Market Challenges
Table 13. TCR-T Therapy Market Restraints
Table 14. Global TCR-T Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global TCR-T Therapy Market Share by Players (2016-2021)
Table 16. Global Top TCR-T Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TCR-T Therapy as of 2020)
Table 17. Ranking of Global Top TCR-T Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by TCR-T Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players TCR-T Therapy Product Solution and Service
Table 21. Date of Enter into TCR-T Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TCR-T Therapy Market Size by Source of T-cells (2016-2021) (US$ Million)
Table 24. Global TCR-T Therapy Revenue Market Share by Source of T-cells (2016-2021)
Table 25. Global TCR-T Therapy Forecasted Market Size by Source of T-cells (2022-2027) (US$ Million)
Table 26. Global TCR-T Therapy Revenue Market Share by Source of T-cells (2022-2027) & (US$ Million)
Table 27. Global TCR-T Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global TCR-T Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global TCR-T Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global TCR-T Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America TCR-T Therapy Market Size by Source of T-cells (2016-2021) (US$ Million)
Table 32. North America TCR-T Therapy Market Size by Source of T-cells (2022-2027) & (US$ Million)
Table 33. North America TCR-T Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America TCR-T Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America TCR-T Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America TCR-T Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe TCR-T Therapy Market Size by Source of T-cells (2016-2021) (US$ Million)
Table 38. Europe TCR-T Therapy Market Size by Source of T-cells (2022-2027) & (US$ Million)
Table 39. Europe TCR-T Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe TCR-T Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe TCR-T Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe TCR-T Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific TCR-T Therapy Market Size by Source of T-cells (2016-2021) (US$ Million)
Table 44. Asia-Pacific TCR-T Therapy Market Size by Source of T-cells (2022-2027) & (US$ Million)
Table 45. Asia-Pacific TCR-T Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific TCR-T Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific TCR-T Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific TCR-T Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America TCR-T Therapy Market Size by Source of T-cells (2016-2021) (US$ Million)
Table 50. Latin America TCR-T Therapy Market Size by Source of T-cells (2022-2027) & (US$ Million)
Table 51. Latin America TCR-T Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America TCR-T Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America TCR-T Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America TCR-T Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa TCR-T Therapy Market Size by Source of T-cells (2016-2021) (US$ Million)
Table 56. Middle East & Africa TCR-T Therapy Market Size by Source of T-cells (2022-2027) & (US$ Million)
Table 57. Middle East & Africa TCR-T Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa TCR-T Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa TCR-T Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa TCR-T Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Athenex Company Details
Table 62. Athenex Business Overview
Table 63. Athenex TCR-T Therapy Product
Table 64. Athenex Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million)
Table 65. Athenex Recent Development
Table 66. Xiangxue Pharmaceutical (Xiangxue Precision) Company Details
Table 67. Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
Table 68. Xiangxue Pharmaceutical (Xiangxue Precision) TCR-T Therapy Product
Table 69. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million)
Table 70. Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development
Table 71. Hengrui Yuanzheng Company Details
Table 72. Hengrui Yuanzheng Business Overview
Table 73. Hengrui Yuanzheng TCR-T Therapy Product
Table 74. Hengrui Yuanzheng Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million)
Table 75. Hengrui Yuanzheng Recent Development
Table 76. Eureka Therapeutics Company Details
Table 77. Eureka Therapeutics Business Overview
Table 78. Eureka Therapeutics TCR-T Therapy Product
Table 79. Eureka Therapeutics Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million)
Table 80. Eureka Therapeutics Recent Development
Table 81. WuXi Juno Company Details
Table 82. WuXi Juno Business Overview
Table 83. WuXi Juno TCR-T Therapy Product
Table 84. WuXi Juno Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million)
Table 85. WuXi Juno Recent Development
Table 86. Shenzhen Inno Immunity Company Details
Table 87. Shenzhen Inno Immunity Business Overview
Table 88. Shenzhen Inno Immunity TCR-T Therapy Product
Table 89. Shenzhen Inno Immunity Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million)
Table 90. Shenzhen Inno Immunity Recent Development
Table 91. Shenzhen Binde Bio Company Details
Table 92. Shenzhen Binde Bio Business Overview
Table 93. Shenzhen Binde Bio TCR-T Therapy Product
Table 94. Shenzhen Binde Bio Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million)
Table 95. Shenzhen Binde Bio Recent Development
Table 96. Kerui Bio Company Details
Table 97. Kerui Bio Business Overview
Table 98. Kerui Bio Revenue in TCR-T Therapy Business (2016-2021) & (US$ Million)
Table 99. Kerui Bio Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global TCR-T Therapy Market Share by Source of T-cells: 2020 VS 2027
Figure 2. Autologous Features
Figure 3. Allogeneic Features
Figure 4. Global TCR-T Therapy Market Share by Application: 2020 VS 2027
Figure 5. Refractory Relapsed Melanoma Case Studies
Figure 6. Synovial Sarcoma Case Studies
Figure 7. Multiple Myeloma Case Studies
Figure 8. Lung Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. TCR-T Therapy Report Years Considered
Figure 11. Global TCR-T Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global TCR-T Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global TCR-T Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global TCR-T Therapy Market Share by Regions (2022-2027)
Figure 15. Global TCR-T Therapy Market Share by Players in 2020
Figure 16. Global Top TCR-T Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TCR-T Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by TCR-T Therapy Revenue in 2020
Figure 18. Global TCR-T Therapy Revenue Market Share by Source of T-cells (2016-2021)
Figure 19. Global TCR-T Therapy Revenue Market Share by Source of T-cells (2022-2027)
Figure 20. North America TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America TCR-T Therapy Market Share by Source of T-cells (2016-2027)
Figure 22. North America TCR-T Therapy Market Share by Application (2016-2027)
Figure 23. North America TCR-T Therapy Market Share by Country (2016-2027)
Figure 24. United States TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe TCR-T Therapy Market Share by Source of T-cells (2016-2027)
Figure 28. Europe TCR-T Therapy Market Share by Application (2016-2027)
Figure 29. Europe TCR-T Therapy Market Share by Country (2016-2027)
Figure 30. Germany TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific TCR-T Therapy Market Share by Source of T-cells (2016-2027)
Figure 38. Asia-Pacific TCR-T Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific TCR-T Therapy Market Share by Region (2016-2027)
Figure 40. China TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America TCR-T Therapy Market Share by Source of T-cells (2016-2027)
Figure 48. Latin America TCR-T Therapy Market Share by Application (2016-2027)
Figure 49. Latin America TCR-T Therapy Market Share by Country (2016-2027)
Figure 50. Mexico TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa TCR-T Therapy Market Share by Source of T-cells (2016-2027)
Figure 54. Middle East & Africa TCR-T Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa TCR-T Therapy Market Share by Country (2016-2027)
Figure 56. Turkey TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE TCR-T Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Athenex Revenue Growth Rate in TCR-T Therapy Business (2016-2021)
Figure 60. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue Growth Rate in TCR-T Therapy Business (2016-2021)
Figure 61. Hengrui Yuanzheng Revenue Growth Rate in TCR-T Therapy Business (2016-2021)
Figure 62. Eureka Therapeutics Revenue Growth Rate in TCR-T Therapy Business (2016-2021)
Figure 63. WuXi Juno Revenue Growth Rate in TCR-T Therapy Business (2016-2021)
Figure 64. Shenzhen Inno Immunity Revenue Growth Rate in TCR-T Therapy Business (2016-2021)
Figure 65. Shenzhen Binde Bio Revenue Growth Rate in TCR-T Therapy Business (2016-2021)
Figure 66. Kerui Bio Revenue Growth Rate in TCR-T Therapy Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界のT細胞移植療法市場規模・現状・予測（2021年-2027年）

Global T Cell Transfer Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z5541 2021年4月 91Pages
QYResearch社発行の本調査資料では、T細胞移植療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自家、同種異系）、用途別市場規模（子供、大人、高齢者）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、...

世界の動物用幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Animal Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0344 2021年4月 98Pages
QYResearch社発行の本調査資料では、動物用幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（犬用幹細胞治療、馬用幹細胞治療、その他動物）、用途別市場規模（獣医病院、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の関節リウマチ幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Rheumatoid Arthritis Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z5046 2021年4月 93Pages
QYResearch社発行の本調査資料では、関節リウマチ幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（同種間葉系幹細胞、骨髄移植、脂肪組織幹細胞）、用途別市場規模（病院、外来手術センター、専門診療所）、主要地域別市場規模（北米、アメ...

世界の犬幹細胞療法市場規模・現状・予測（2021年-2027年）

Global Canine Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1084 2021年4月 92Pages
QYResearch社発行の本調査資料では、犬幹細胞療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（同種幹細胞、自家幹細胞）、用途別市場規模（獣医病院、獣医クリニック、獣医研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の遺伝子治療薬市場規模・現状・予測（2021年-2027年）

Global Drugs Based on Gene Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1998 2021年4月 93Pages
QYResearch社発行の本調査資料では、遺伝子治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ウイルス用、非ウイルス用）、用途別市場規模（神経疾患、がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓...

世界の微生物燃料電池（MFC）市場規模・現状・予測（2021年-2027年）

Global Microbial Fuel Cells (MFC) Market Size, Status and Forecast 2021-2027
QYR2104Z3752 2021年4月 99Pages
QYResearch社発行の本調査資料では、微生物燃料電池（MFC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（仲介MFC、非仲介MFC）、用途別市場規模（農業、医療、食品・飲料、政府・都市用、その他）、主要地域別市場規模（北米、アメリカ、...

世界の循環腫瘍細胞（CTC）・がん幹細胞（CSC）市場規模・現状・予測（2021年-2027年）

Global Circulating Tumor Cells and Cancer Stem Cells Market Size, Status and Forecast 2021-2027
QYR2104Z1342 2021年4月 95Pages
QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）・がん幹細胞（CSC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細胞濃縮、検出、CTC分析）、用途別市場規模（病院、NSC、医学研究機関）、主要地域別市場規模（北米、アメリ...

世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年）

Global Circulating Tumor Cells (CTC) Market Size, Status and Forecast 2021-2027
QYR2104Z1340 2021年4月 96Pages
QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エクスビボポジティブセレクション、インビボポジティブセレクション、ネガティブセレクション、マイクロチップ・シングルスパイラルマイク...

世界の循環腫瘍細胞（CTC）予後技術市場規模・現状・予測（2021年-2027年）

Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, Status and Forecast 2021-2027
QYR2104Z1341 2021年4月 99Pages
QYResearch社発行の本調査資料では、循環腫瘍細胞（CTC）予後技術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍細胞濃縮、腫瘍細胞検出）、用途別市場規模（前立腺がん、乳がん、結腸直腸がん、肺がん、卵巣がん、膵臓がん）、主要地域別市...

世界のmRNA療法市場規模・現状・予測（2021年-2027年）

Global mRNA Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z3936 2021年4月 94Pages
QYResearch社発行の本調査資料では、mRNA療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ワクチン、治療薬）、用途別市場規模（mRNA標的化送達in vivo、遺伝子改変T細胞、癌免疫療法開発用ナノ粒子形質転換、小分子創薬）、主要...

世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
世界の小分子標的がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Cancer Therapy Market The global Small Molecule Targeted Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
世界のT細胞移植療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global T Cell Transfer Therapy Market The global T Cell Transfer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…